Vitamin D for the treatment of painful diabetic neuropathy

Abdul Basit, Khalid Abdul Basit, Asher Fawwad, Fariha Shaheen, Nimra Fatima, Ioannis N Petropoulos, Uazman Alam, Rayaz A Malik, Abdul Basit, Khalid Abdul Basit, Asher Fawwad, Fariha Shaheen, Nimra Fatima, Ioannis N Petropoulos, Uazman Alam, Rayaz A Malik

Abstract

Objective: To assess the effect of high-dose vitamin D in patients with painful diabetic neuropathy.

Methods: A single intramuscular dose of 600 000 IU vitamin D was administered, and the effects on metabolic parameters and neuropathic pain assessed over 20 weeks.

Results: 143 participants with predominantly type 2 diabetes, aged 52.31±11.48 years, with a Douleur Neuropathique 4 (DN4) score (3.0±1.8), total McGill pain score (21.2±14.9), and Short Form McGill Pain Questionnaire (SFMPQ) score (2.1±0.9), were enrolled. The baseline 25-hydroxyvitamin D (25(OH)D) level was 31.7±23.3 ng/mL and 58 (40.5%) patients showed evidence of vitamin D deficiency (25(OH)D<20 ng/mL). Intramuscular administration of vitamin D resulted in a significant increase in 25(OH)D (46.2±10.2 ng/mL, p<0.0001) and a reduction in positive symptoms on the DN4 (p<0.0001), total pain score (p<0.0001), and SFMPQ (p<0.0001).

Conclusions: Treatment with a single intramuscular dose of 600 000 IU of vitamin D in patients with painful diabetic neuropathy is associated with a significant decrease in the symptoms of painful diabetic neuropathy.

Trial registration number: BIDE-12/2014.

Keywords: Neuropathy Complications; Neuropathy and Clinical Diabetes; Pain; Vitamin D.

References

    1. Abbott CA, Malik RA, van Ross ER et al. . Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes care 2011;34:2220–4. 10.2337/dc11-1108
    1. Tesfaye S, Vileikyte L, Rayman G et al. . Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2011;27:629–38. 10.1002/dmrr.1225
    1. Sadosky A, Schaefer C, Mann R et al. . Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes 2013;6:79–92. 10.2147/DMSO.S37415
    1. Tesfaye S, Boulton AJ, Dyck PJ et al. . Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285–93. 10.2337/dc10-1303
    1. Bril V, England J, Franklin GM et al. , American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011;76:1758–65.
    1. Tesfaye S, Wilhelm S, Lledo A et al. . Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study”—a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain 2013;154:2616–25. 10.1016/j.pain.2013.05.043
    1. Wilkinson ID, Selvarajah D, Greig M et al. . Magnetic resonance imaging of the central nervous system in diabetic neuropathy. Curr Diab Rep 2013;13:509–16. 10.1007/s11892-013-0394-8
    1. Oyibo SO, Prasad YD, Jackson NJ et al. . The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002;19:870–3. 10.1046/j.1464-5491.2002.00801.x
    1. Bierhaus A, Fleming T, Stoyanov S et al. . Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012;18:926–33. 10.1038/nm.2750
    1. Soderstrom LH, Johnson SP, Diaz VA et al. . Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med 2012;29:50–5. 10.1111/j.1464-5491.2011.03379.x
    1. Shehab D, Al-Jarallah K, Mojiminiyi OA et al. . Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med 2012;29:43–9. 10.1111/j.1464-5491.2011.03510.x
    1. Alamdari A, Mozafari R, Tafakhori A et al. . An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects. Neurol Sci 2015;36:1121–6. 10.1007/s10072-015-2207-0
    1. Maser RE, Lenhard MJ, Pohlig RT. Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes. Endocr Pract 2015;21:174–81. 10.4158/EP14332.OR
    1. Lv WS, Zhao WJ, Gong SL et al. . Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J Endocrinol Invest 2015;38:513–18. 10.1007/s40618-014-0210-6
    1. Celikbilek A, Gocmen AY, Tanik N et al. . Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey. Acta Neurol Belg 2015;115:47–52. 10.1007/s13760-014-0304-0
    1. Herrmann M, Sullivan DR, Veillard AS et al. . Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 2015;38:521–8. 10.2337/dc14-0180
    1. Hirani V. Vitamin D status and pain: analysis from the Health Survey for England among English adults aged 65 years and over. Br J Nutr 2012;107:1080–4. 10.1017/S0007114511003965
    1. Tague SE, Smith PG. Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones. J Chem Neuroanat 2011;41:1–12. 10.1016/j.jchemneu.2010.10.001
    1. Tague SE, Clarke GL, Winter MK et al. . Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation. J Neurosci 2011;31:13728–38. 10.1523/JNEUROSCI.3637-11.2011
    1. Hellweg R, Wohrle M, Hartung HD et al. . Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation. Neurosci Lett 1991;125:1–4. 10.1016/0304-3940(91)90114-9
    1. Anand P, Terenghi G, Warner G et al. . The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996;2:703–7. 10.1038/nm0696-703
    1. Fukuoka M, Sakurai K, Ohta T et al. . Tacalcitol, an active vitamin D3, induces nerve growth factor production in human epidermal keratinocytes. Skin Pharmacol Appl Skin Physiol 2001;14:226–33.
    1. Wergeland S, Torkildsen O, Myhr KM et al. . Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS ONE 2011;6:e26262 10.1371/journal.pone.0026262
    1. Bianco J, Gueye Y, Marqueste T et al. . Vitamin D(3) improves respiratory adjustment to fatigue and H-reflex responses in paraplegic adult rats. Neuroscience 2011;188:182–92. 10.1016/j.neuroscience.2011.04.066
    1. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008;168:771–2. 10.1001/archinte.168.7.771
    1. Shehab D, Al-Jarallah K, Abdella N et al. . Prospective evaluation of the effect of short-term oral vitamin D supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract 2015;24:250–6. 10.1159/000375304
    1. Hawker GA, Mian S, Kendzerska T et al. . Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S240–52. 10.1002/acr.20543
    1. Cipriani C, Romagnoli E, Scillitani A et al. . Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 2010;95:4771–7. 10.1210/jc.2010-0502
    1. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471–8. 10.1210/jc.2009-1773
    1. Iqbal R, Jafri L, Haroon A et al. . Illuminating the dark side—vitamin D status in different localities of Karachi. J Coll Physicians Surg Pak 2013;23:604–6.
    1. Khan AH, Iqbal R, Naureen G et al. . Prevalence of vitamin D deficiency and its correlates: results of a community-based study conducted in Karachi, Pakistan. Arch Osteoporos 2012;7:275–82. 10.1007/s11657-012-0108-x
    1. Mansoor S, Habib A, Ghani F et al. . Prevalence and significance of vitamin D deficiency and insufficiency among apparently healthy adults. Clin Biochem 2010;43:1431–5. 10.1016/j.clinbiochem.2010.09.022
    1. Shaheen S, Noor SS, Barakzai Q. Serum alkaline phosphatase screening for vitamin D deficiency states. J Coll Physicians Surg Pak 2012;22:424–7.
    1. Sheikh A, Saeed Z, Jafri SA et al. . Vitamin D levels in asymptomatic adults—a population survey in Karachi, Pakistan. PLoS ONE 2012;7:e33452 10.1371/journal.pone.0033452
    1. Tavakoli M, Asghar O, Alam U et al. . Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy. Ther Adv Endocrinol Metab 2010;1:69–88. 10.1177/2042018810370954
    1. Valensi P, Le Devehat C, Richard JL et al. . A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complications 2005;19:247–53. 10.1016/j.jdiacomp.2005.05.011
    1. Bell DS. Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient. Case Rep Endocrinol 2012;2012:165056 10.1155/2012/165056
    1. Girgis CM, Clifton-Bligh RJ, Hamrick MW et al. . The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 2013;34:33–83. 10.1210/er.2012-1012
    1. Riaz S, Malcangio M, Miller M et al. . A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 1999;42:1308–13. 10.1007/s001250051443
    1. Dalgard C, Petersen MS, Weihe P et al. . Vitamin D status in relation to glucose metabolism and type 2 diabetes in septuagenarians. Diabetes care 2011;34:1284–8. 10.2337/dc10-2084
    1. Alam U, Najam O, Al-Himdani S et al. . Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia. Diabet Med 2012;29:1343–5. 10.1111/j.1464-5491.2012.03692.x

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe